Search Results - "van Harten, WH"

Innovations that reach the patient: early health technology assessment and improving the chances of coverage and implementation by van Harten, W H, Retèl, V P

“…With growing concerns for the sustainability of the financial burden that health care-and especially cancer services-poses on the national budgets, the role of…”
Get full text

Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology by van Harten, W H, Retèl, V P

“…The Organisation of European Cancer Institutes OECI working group on Health Economics and Cost Benefit in Oncology suggests four actions that are needed to…”
Get full text

A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors by Kuijpers, Wilma, Groen, Wim G, Aaronson, Neil K, van Harten, Wim H

“…Patient empowerment reflects the ability of patients to positively influence their health and health behavior such as physical activity. While interactive…”
Get full text

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study by Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

“…The 70‐gene signature (MammaPrint™) has been developed on retrospective series of breast cancer patients to predict the risk of breast cancer distant…”
Get full text

Evaluating quality of patient care communication in integrated care settings: a mixed method approach by Gulmans, J., Vollenbroek-Hutten, M.M.R., Van Gemert-Pijnen, J.E.W.C., Van Harten, W.H.

“…AbstractBackground Owing to the involvement of multiple professionals from various institutions, integrated care settings are prone to suboptimal patient care…”
Get full text

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review by Beck, ACC, Retèl, VP, Bhairosing, PA, van den Brekel, MWM, van Harten, WH

“…•Across Europe, market access is uniform, whereas reimbursement procedures are heterogeneous.•Time to access is mainly influenced by reimbursement…”
Get full text

Abstract P4-12-01: MammaPrint is cost-effective compared to clinical risk assessment in early stage breast cancer by Retèl, VP, Joore, MA, van 't Veer, LJ, Cardoso, F, Piccart, MJ, Rutgers, EJ, Tryfonidis, K, Poncet, C, van Harten, WH

“…Abstract Rationale: The 70-gene signature (MammaPrint®, MP) is a prognostic test which guides treatment decisions in patients with early breast cancer. After…”
Get full text

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial by Akdemir, Emine, Sweegers, Maike G, Vrieling, Alina, Rundqvist, Helene, Meijer, Richard P, Leliveld-Kors, Annemarie M, van der Heijden, Antoine G, Rutten, Vera C, Koldewijn, Evert L, Bos, Siebe D, Wijburg, Carl J, Marcelissen, Tom A T, Bongers, Bart C, Retèl, Valesca P, van Harten, Wim H, May, Anne M, Groen, Wim G, Stuiver, Martijn M

“…IntroductionRadical cystectomy (RC) is the standard treatment for patients with non-metastatic muscle-invasive bladder cancer, as well as for patients with…”
Get full text

COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS by Miquel-Cases, A, Steuten, L, Rigter, L, van Harten, WH

Get full text

PCN186 - COST-EFFECTIVENESS AND FEASIBILITY OF IMPLEMENTING MRI-GUIDED NEOADJUVANT CHEMOTHERAPY TO TREAT ER-POSITIVE HER2-NEGATIVE BREAST CANCERS IN THE NETHERLANDS by Miquel-Cases, A, Steuten, L, Rigter, L, van Harten, WH

Get full text

A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer by Retèl, VP, van Lieshout, C, Koole, S, Sikorska, K, Sonke, GS, van Driel, WJ, van Harten, WH

“…OBJECTIVES: Hyperthermic intraperitoneal chemotherapy (HIPEC) is a new addition to standard treatment of stage III ovarian cancer with neoadjuvant chemotherapy…”
Get full text

PCN121 - A Health Technology Assessment of Hyperthermic Intraperitoneal Chemotherapy Added to Interval Cytoreductive Surgery in Stage III Ovarian Cancer by Retèl, VP, van Lieshout, C, Koole, S, Sikorska, K, Sonke, GS, van Driel, WJ, van Harten, WH

Get full text

MD4 - Cost-Effectiveness of 18f-Fdg Pet/Ct for Screening Distant Metastasis in Stage Ii/Iii Breast Cancer Patients of the UK, the United States and the Netherlands by Miquel-Cases, A, Teixeira, S, Retèl, V, Steuten, L, Valdés Olmos, R, Rutgers, E, van Harten, WH

Get full text

Abstract P6-12-06: Effect and moderators of exercise on fatigue in patients with breast cancer: Meta-analysis of individual patient data by van Vulpen, JK, Sweegers, MG, Kalter, J, Peeters, PH, Courneya, KS, Newton, RU, Aaronson, NK, Jacobsen, PB, Steindorf, K, Stuiver, MM, Hayes, S, Mesters, I, Knoop, H, Goedendorp, M, Mutrie, N, Thorsen, L, Schmidt, M, Sonke, GS, Bohus, M, James, EL, Oldenburg, HS, Velthuis, MJ, Nollet, F, Wenzel, J, Wiskemann, J, Galvão, DA, Chinapaw, MJ, Irwin, ML, Griffith, KA, van Weert, E, Daley, AJ, McConnachie, A, Schulz, K-H, Short, CE, Plotnikoff, RC, Potthoff, K, van Beurden, M, van Harten, WH, Schmitz, KH, Winters-Stone, KM, Taaffe, DR, van Mechelen, W, Kersten, M-J, Verdonck-de Leeuw, IM, Brug, J, Buffart, LM, May, AM

“…Abstract Background - Fatigue is one of the most common and disabling complaints in patients with breast cancer and can effectively be reduced by physical…”
Get full text

An exact approach for relating recovering surgical patient workload to the master surgical schedule by Vanberkel, P T, Boucherie, R J, Hans, E W, Hurink, J L, van Lent, W A M, van Harten, W H

“…No other department influences the workload of a hospital more than the Department of Surgery and in particular, the activities in the operating room. These…”
Get full text

Cost-Effectiveness of 18f-Fdg Pet/Ct for Screening Distant Metastasis in Stage Ii/Iii Breast Cancer Patients of the UK, the United States and the Netherlands by Miquel-Cases, A, Teixeira, S, Retèl, V, Steuten, L, Valdés Olmos, R, Rutgers, E, van Harten, WH

Get full text

Abstract P6-06-13: Optimized prediction of clinical outcome by the PREDICT plus tool and the 70-gene signature in early stage node-negative breast cancer by Drukker, CA, Nijenhuis, MV, Bueno-de-Mesquita, JM, Retel, VP, van Tinteren, H, Schmidt, MK, van Harten, WH, Sonke, GS, van 't Veer, LJ, Rutgers, EJ, van de Vijver, MJ, Linn, SC

“…Abstract Background Established breast cancer guidelines and online tools use clinico-pathological factors including age, tumor size and grade to evaluate the…”
Get full text

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies by Rajan, A., Berns, A., Ringborg, U., Celis, J., Ponder, B., Caldas, C., Livingston, D., Bristow, R.G., Hecht, T.T., Tursz, T., van Luenen, H., Bono, P., Helander, T., Seamon, K., Smyth, J.F., Louvard, D., Eggermont, A., van Harten, W.H.

“…Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System…”
Get full text

Successfully Improving Physical Activity Behavior after Rehabilitation by van der Ploeg, Hidde P., Streppel, Kitty R. M., van der Beek, Allard J., van der Woude, Luc H. V., Vollenbroek-Hutten, Miriam M. R., van Harten, Wim H., van Mechelen, Willem

“…Purpose. To determine the effects of the physical activity promotion programs Rehabilitation & Sports (R&S) and Active after Rehabilitation (AaR) on sport and…”
Get full text

Counselling increases physical activity behaviour nine weeks after rehabilitation by van der Ploeg, H P, Streppel, K R M, van der Beek, A J, van der Woude, L H V, Vollenbroek-Hutten, M M R, van Harten, W H, van Mechelen, W

“…Background: For people with disabilities, a physically active lifestyle can reduce the risk of secondary health problems and improve overall functioning…”
Get full text